Correlates of myalgia in electroconvulsive therapy

Keith G. Rasmussen, Kristin N. Petersen, Jessica L. Sticka, LaChelle J. Wieme, Jason H. Zosel, Marie E S Marienau, Debra A. Ryan, Darrel R. Schroeder, Susanna R. Stevens, W. Michael Hooten, Thomas N. Spackman

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Myalgias are common in patients treated with electroconvulsive therapy (ECT). The mechanism of this side effect is unknown. Two commonly postulated etiologies are the motor activity during the convulsion and the fasciculations induced by succinylcholine. If the former phenomenon accounts for most of themyalgias, then the appropriate strategy will be to increase the succinylcholine dose at subsequent treatments. If, on the other hand, the latter phenomenon is more important in inducing myalgias, then the appropriate strategy may be to decrease succinylcholine dosages (on the theory that lower doses result in less fasciculating). On the other hand, if neither of these factors accounts for myalgias, then succinylcholine dose adjustments may be irrelevant to myalgias in the ECT situation. In this study, we assessed the degree of convulsive movements during the seizure as well as strength of fasciculations caused by succinylcholine to see which, if either, correlates with ultimate complaints of myalgias. The results indicated that neither of these factors, nor dose of succinylcholine, correlated with myalgias. We conclude that dose adjustments to succinylcholine are unlikely to affect complaints of myalgias in ECT patients.

Original languageEnglish (US)
Pages (from-to)84-87
Number of pages4
JournalJournal of ECT
Volume24
Issue number1
DOIs
StatePublished - Mar 2008

Fingerprint

Succinylcholine
Electroconvulsive Therapy
Myalgia
Fasciculation
Social Adjustment
Seizures
Motor Activity

Keywords

  • Electroconvulsive therapy
  • Myalgia
  • Succinylcholine

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Rasmussen, K. G., Petersen, K. N., Sticka, J. L., Wieme, L. J., Zosel, J. H., Marienau, M. E. S., ... Spackman, T. N. (2008). Correlates of myalgia in electroconvulsive therapy. Journal of ECT, 24(1), 84-87. https://doi.org/10.1097/YCT.0b013e31814b17e6

Correlates of myalgia in electroconvulsive therapy. / Rasmussen, Keith G.; Petersen, Kristin N.; Sticka, Jessica L.; Wieme, LaChelle J.; Zosel, Jason H.; Marienau, Marie E S; Ryan, Debra A.; Schroeder, Darrel R.; Stevens, Susanna R.; Hooten, W. Michael; Spackman, Thomas N.

In: Journal of ECT, Vol. 24, No. 1, 03.2008, p. 84-87.

Research output: Contribution to journalArticle

Rasmussen, KG, Petersen, KN, Sticka, JL, Wieme, LJ, Zosel, JH, Marienau, MES, Ryan, DA, Schroeder, DR, Stevens, SR, Hooten, WM & Spackman, TN 2008, 'Correlates of myalgia in electroconvulsive therapy', Journal of ECT, vol. 24, no. 1, pp. 84-87. https://doi.org/10.1097/YCT.0b013e31814b17e6
Rasmussen KG, Petersen KN, Sticka JL, Wieme LJ, Zosel JH, Marienau MES et al. Correlates of myalgia in electroconvulsive therapy. Journal of ECT. 2008 Mar;24(1):84-87. https://doi.org/10.1097/YCT.0b013e31814b17e6
Rasmussen, Keith G. ; Petersen, Kristin N. ; Sticka, Jessica L. ; Wieme, LaChelle J. ; Zosel, Jason H. ; Marienau, Marie E S ; Ryan, Debra A. ; Schroeder, Darrel R. ; Stevens, Susanna R. ; Hooten, W. Michael ; Spackman, Thomas N. / Correlates of myalgia in electroconvulsive therapy. In: Journal of ECT. 2008 ; Vol. 24, No. 1. pp. 84-87.
@article{fda9858f1a1242458ebf957f772427f4,
title = "Correlates of myalgia in electroconvulsive therapy",
abstract = "Myalgias are common in patients treated with electroconvulsive therapy (ECT). The mechanism of this side effect is unknown. Two commonly postulated etiologies are the motor activity during the convulsion and the fasciculations induced by succinylcholine. If the former phenomenon accounts for most of themyalgias, then the appropriate strategy will be to increase the succinylcholine dose at subsequent treatments. If, on the other hand, the latter phenomenon is more important in inducing myalgias, then the appropriate strategy may be to decrease succinylcholine dosages (on the theory that lower doses result in less fasciculating). On the other hand, if neither of these factors accounts for myalgias, then succinylcholine dose adjustments may be irrelevant to myalgias in the ECT situation. In this study, we assessed the degree of convulsive movements during the seizure as well as strength of fasciculations caused by succinylcholine to see which, if either, correlates with ultimate complaints of myalgias. The results indicated that neither of these factors, nor dose of succinylcholine, correlated with myalgias. We conclude that dose adjustments to succinylcholine are unlikely to affect complaints of myalgias in ECT patients.",
keywords = "Electroconvulsive therapy, Myalgia, Succinylcholine",
author = "Rasmussen, {Keith G.} and Petersen, {Kristin N.} and Sticka, {Jessica L.} and Wieme, {LaChelle J.} and Zosel, {Jason H.} and Marienau, {Marie E S} and Ryan, {Debra A.} and Schroeder, {Darrel R.} and Stevens, {Susanna R.} and Hooten, {W. Michael} and Spackman, {Thomas N.}",
year = "2008",
month = "3",
doi = "10.1097/YCT.0b013e31814b17e6",
language = "English (US)",
volume = "24",
pages = "84--87",
journal = "Journal of ECT",
issn = "1095-0680",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Correlates of myalgia in electroconvulsive therapy

AU - Rasmussen, Keith G.

AU - Petersen, Kristin N.

AU - Sticka, Jessica L.

AU - Wieme, LaChelle J.

AU - Zosel, Jason H.

AU - Marienau, Marie E S

AU - Ryan, Debra A.

AU - Schroeder, Darrel R.

AU - Stevens, Susanna R.

AU - Hooten, W. Michael

AU - Spackman, Thomas N.

PY - 2008/3

Y1 - 2008/3

N2 - Myalgias are common in patients treated with electroconvulsive therapy (ECT). The mechanism of this side effect is unknown. Two commonly postulated etiologies are the motor activity during the convulsion and the fasciculations induced by succinylcholine. If the former phenomenon accounts for most of themyalgias, then the appropriate strategy will be to increase the succinylcholine dose at subsequent treatments. If, on the other hand, the latter phenomenon is more important in inducing myalgias, then the appropriate strategy may be to decrease succinylcholine dosages (on the theory that lower doses result in less fasciculating). On the other hand, if neither of these factors accounts for myalgias, then succinylcholine dose adjustments may be irrelevant to myalgias in the ECT situation. In this study, we assessed the degree of convulsive movements during the seizure as well as strength of fasciculations caused by succinylcholine to see which, if either, correlates with ultimate complaints of myalgias. The results indicated that neither of these factors, nor dose of succinylcholine, correlated with myalgias. We conclude that dose adjustments to succinylcholine are unlikely to affect complaints of myalgias in ECT patients.

AB - Myalgias are common in patients treated with electroconvulsive therapy (ECT). The mechanism of this side effect is unknown. Two commonly postulated etiologies are the motor activity during the convulsion and the fasciculations induced by succinylcholine. If the former phenomenon accounts for most of themyalgias, then the appropriate strategy will be to increase the succinylcholine dose at subsequent treatments. If, on the other hand, the latter phenomenon is more important in inducing myalgias, then the appropriate strategy may be to decrease succinylcholine dosages (on the theory that lower doses result in less fasciculating). On the other hand, if neither of these factors accounts for myalgias, then succinylcholine dose adjustments may be irrelevant to myalgias in the ECT situation. In this study, we assessed the degree of convulsive movements during the seizure as well as strength of fasciculations caused by succinylcholine to see which, if either, correlates with ultimate complaints of myalgias. The results indicated that neither of these factors, nor dose of succinylcholine, correlated with myalgias. We conclude that dose adjustments to succinylcholine are unlikely to affect complaints of myalgias in ECT patients.

KW - Electroconvulsive therapy

KW - Myalgia

KW - Succinylcholine

UR - http://www.scopus.com/inward/record.url?scp=41849123122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41849123122&partnerID=8YFLogxK

U2 - 10.1097/YCT.0b013e31814b17e6

DO - 10.1097/YCT.0b013e31814b17e6

M3 - Article

C2 - 18379340

AN - SCOPUS:41849123122

VL - 24

SP - 84

EP - 87

JO - Journal of ECT

JF - Journal of ECT

SN - 1095-0680

IS - 1

ER -